Investing.com - Haemonetics (NYSE:HAE) reported on Monday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Haemonetics announced earnings per share of $0.83 on revenue of $297.48M. Analysts polled by Investing.com anticipated EPS of $0.68 on revenue of $270.46M.
Haemonetics shares are down 17.71% from the beginning of the year, still down 6.18% from its 52 week high of $85.97 set on November 1.
Haemonetics follows other major Healthcare sector earnings this month
Haemonetics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar